Dietary fatty acids and coronary heart disease

Lipids

Volumn 34, Issue 1, 1999, Pages

  Nordøy, Arne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORONARY RISK; DIET SUPPLEMENTATION; DRUG EFFECT; FAT INTAKE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM;

EID: 0033000747     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02562223     Document Type: Conference Paper

References (26)

1. Scandinavian Simvastatin Survival Study Group (1994) Randomized Trial of Cholesterol-Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S), Lancet 344, 1863-1869.
2. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKilop, J.H., and Packard, C.C. (1995) Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia, N. Engl. J. Med. 20, 1301-1307.
3. Sacks, F.M., Pfeiffer, M.D., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, J.M.O., Wun, C.-C., Davis, B.R., and Braunwald, E. (1996) The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels, N. Engl. J. Med. 334, 1001-1009.
4. Simes, R.J., Watson, J., Anderson, N., Hankey, G., Simes, S., and Tonkin, A. (1998) Pravastatin Reduces Total Mortality in Patients with Coronary Heart Disease and Average Cholesterol Levels: Relationship of Baseline Cholesterol and Treatment Effect in the LIPID Trial, J. Am. Coll. Cardiac (Abstr.) 31, 1116-1124.
5. Gould, A.L., Rossouw, J.E., Santanello, N.C., Heyse, J.F., and Furberg, C.D. (1998) Cholesterol Reduction Yields Clinical Benefit, Circulation 97, 946-952.
6. Verschuren, W.M.M., Jacobs, D.R., Bloemberg, B.P.M., Kromhout, D., Menotti, K., Aravanis, Q., Blackburn, H., Buzinar, R., Dontas, A.S., and Froanza, F. (1995) Serum Total Cholesterol and Long-Term Coronary Heart Disease Mortality in Different Cultures, JAMA 274, 131-136.
7. Committee on Diet and Health Food and Nutrition Board Commission on Life Sciences National Research Council (1989), in Diet and Health: Implications for Reducing Chronic Disease Risk, pp. 161-168, National Academy Press, Washington, D.C.
8. Strøm, A., and Jensen, R.A. (1952) Mortality from Circulatory Diseases in Norway, Lancet 1, 126-130.
9. Keys, A. (1957) Diet and the Epidemiology of Coronary Heart Disease, JAMA 164, 1912-1919.
10. Dawber, T.R., Moore, F.E., and Makk, G.V. (1957) Coronary Heart Disease in the Framingham Study, Am. J. Pub. Health 47, suppl. April, 4-24.
11. Okuyama, H., Kobayashi, T., and Watawabe, S. (1997) Dietary Fatty Acids - the n-6/n-3 Balance and Chronic Elderly Diseases. Excess Linoleic Acid and Relative n-3 Deficiency Syndrome Seen in Japan, Progr. Lipid Res. 35, 409-457.
12. Dyerberg, J., Bang, H.O., Stoffersen, E., Moncada, S., and Vane, J.R. (1978) Eicosapentaenoic Acid and Prevention of Thrombosis and Atherosclerosis, Lancet 2, 117-119.
13. Nestel, P.J. (1995) Controlling Coronary Risk Through Nutrition, Am. J. Cardiol. 11, suppl. 6, 9-14.
14. Hu, F.B., Stampfer, M.J., Manson, J.E., Rinn, E., Colditz, G.A., Rosner, B.A., Hennekens, C.H., and Willett, W.C. (1997) Dietary Fat Intake and the Risk of Coronary Heart Disease in Women, N. Engl. J. Med. 337, 1491-1499.
15. Esrey, K.L., Joseph, L., and Grover, S.A. (1996) Relationship Between Dietary Intake and Coronary Heart Disease Mortality: Lipid Research Clinics Prevalence Follow-Up Study, J. Clin. Epidemiol. 49, 211-216.
16. Nordøy, A. (1996) Fish Consumption and Cardiovascular Disease: A Reappraisal, Nutr. Metab. Cardiovasc. Dis. 6, 103-109.
17. Billman, G.E., Hallag, H., and Leaf, A. (1994) Prevention of Ischemia-Induced Ventricular Fibrillation by ω-3 Fatty Acids, Proc. Natl. Acad. Sci. USA, 91, 4427-4430.
18. McLennan, P.L., Bridle, T.M., Abeywardena, M.Y., and Charnock, J.S. (1992) Dietary Lipid Modulation of Ventricular Fibrillation Threshold in the Marmoset Monkey, Am. Heart J. 123, 1555-1561.
19. Sisovick, D.S., Raghuthan, T.E., King, I., Weinman, S., Wicklund, K.G., Albright, J., Boubjerg, M., Arbogast, P., Smith, H., Kushi, L.H., Cobb, L.A., Copass, M.K., Psaty, B.M., Lemaitre, R., Retzlaff, B., Childs, M., and Knopp, R.H. (1995) Dietary Intake and Cell Membrane Levels of Long-Chain n-3 Polyunsaturated Fatty Acids and the Risk of Primary Cardiac Arrest, JAMA 274, 1363-1367.
20. Burr, M.L., Gilbert, J.F., Holliday, R.M., Elwood, P.C., Fehily, A.M., Rogers, S., Sweetnam, P.M., and Deadman, N.M. (1989) Effects of Changes in Fat, Fish and Fibre Intakes on Death and Myocardial Reinfarction: Diet and Reinfarction Trial (DART), Lancet 2, 757-761.
21. deLorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J.L., Monjaud, I., Guidollet, J., Touboul, P., and Delaje, J. (1994) Mediterranean Alpha-Linolenic Acid-Rich Diet in Secondary Prevention of Coronary Heart Disease, Lancet 143, 1454-1459.
22. Multiple Risk Factor Intervention Trial. Research Group (1982) Multiple Risk Factor Intervention Trial, JAMA 248, 1465-1477.
23. Hjermann, I., Byre, K.V., Holme, I., and Leren, P. (1981) Effect of Diet and Smoking Intervention on the Incidence of Coronary Heart Disease. Report from the Oslo Study Group of a Randomized Trial in Healthy Men, Lancet 2, 1303-1310.
24. Hjermann, I., Holme, I., and Leren, P. (1986) Oslo Study Diet and Anti-Smoking Trial. Results After 102 Months, Am. J. Med. 80, suppl. 2A, 7-11.
25. Contacos, C., Barter, P.J., and Sullivan, D.R. (1993) Effect of Pravastatin and ω-3 Fatty Acids on Plasma Lipids and Lipoproteins in Patients with Combined Hyperlipemia, Arterioscler. Thromb. 13, 1755-1762.
26. Nordøy, A., Bønaa, K.H., Nilsen, H., Berg, R.K., Hansen, J.B., and Ingebretsen, O.C. (1998) Effects of Simvastatin and Omega-3 Fatty Acids on Plasma Lipoproteins and Lipid Peroxidation in Patients with Combined Hyperlipemia, J. Intern. Med. 242, 163-170.